{
    "clinical_study": {
        "@rank": "8298", 
        "arm_group": [
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo tablet"
            }, 
            {
                "arm_group_label": "Intervention", 
                "arm_group_type": "Experimental", 
                "description": "Iodine tablet"
            }
        ], 
        "brief_summary": {
            "textblock": "The study hypothesis is that iodine supplementation will lower serum TSH and leptin\n      concentrations and thereby improve the lipid and glucose profile."
        }, 
        "brief_title": "Iodine Supplementation in Obesity", 
        "completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Iodine Deficiency", 
            "Subclinical Hypothyroidism"
        ], 
        "condition_browse": {
            "mesh_term": "Hypothyroidism"
        }, 
        "detailed_description": {
            "textblock": "The study will be a double blind, placebo controlled intervention study in obese women\n      living in the Atlas foot mountains in Morocco, an iodine deficient area. Eligible subjects\n      will be randomized into intervention and control group and will receive the respective\n      supplement for 6 months. At baseline, midpoint and endpoint anthropometric as well as\n      metabolic profile will be assessed. A health questionnaire will further be administered\n      monthly when the tablets for the following month are distributed. Urine samples to determine\n      iodine status will also be collected monthly."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Women of reproductive age (20 to 50 years)\n\n          -  Body mass index 27 to 40 kg/m2\n\n          -  Having received oral and written information about the aims and procedures of the\n             study\n\n          -  Willing to comply with the study procedure\n\n          -  Having provided oral and written informed consent\n\n        Exclusion Criteria:\n\n          -  Chronic disease or gastrointestinal disorders\n\n          -  Nodular goiter\n\n          -  Regular use of medication (except oral contraceptives)\n\n          -  Pregnancy or lactation\n\n          -  Subject who cannot be expected to comply with study protocol"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "50 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "162", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 31, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01985204", 
            "org_study_id": "EK 2013-N-24"
        }, 
        "intervention": [
            {
                "arm_group_label": "Intervention", 
                "description": "Iodine tablets containing 200 ug iodine as potassium iodate", 
                "intervention_name": "Iodine tablet", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Placebo tablet without iodine", 
                "intervention_name": "Placebo tablet", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Iodine", 
                "Cadexomer iodine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "iodine", 
            "thyroid hormones", 
            "obesity", 
            "TSH", 
            "dyslipidemia", 
            "insulin resistance"
        ], 
        "lastchanged_date": "June 2, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Marrakech", 
                        "country": "Morocco"
                    }, 
                    "name": "University Cadi Ayyad, Faculte des Sciences"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Marrakech", 
                        "country": "Morocco"
                    }, 
                    "name": "Universite Caddi Ayad, Faculte de Medecine et de Pharmacie"
                }
            }
        ], 
        "location_countries": {
            "country": "Morocco"
        }, 
        "number_of_arms": "2", 
        "official_title": "Assessment of the Improvement of the Cardiovascular Risk Profile in Obese Women After Correction of Iodine Deficiency", 
        "other_outcome": [
            {
                "measure": "T3", 
                "safety_issue": "No", 
                "time_frame": "baseline, 3 months and 6 months"
            }, 
            {
                "measure": "T4", 
                "safety_issue": "No", 
                "time_frame": "baseline, 3 months and 6 months"
            }, 
            {
                "measure": "total cholesterol", 
                "safety_issue": "No", 
                "time_frame": "baseline, 3 months and 6 months"
            }, 
            {
                "measure": "TSH", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "measure": "leptin", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }
        ], 
        "overall_official": {
            "affiliation": "ETH Zurich, Switzerland", 
            "last_name": "Isabelle Aeberli, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Switzerland: Ethikkommission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "Change in TSH (thyroid-stimulating hormone)", 
                "safety_issue": "No", 
                "time_frame": "change from baseline to 6 months"
            }, 
            {
                "measure": "change in fasting insulin", 
                "safety_issue": "No", 
                "time_frame": "change from baseline to 6 months"
            }, 
            {
                "measure": "change in the LDL cholesterol/ HDL cholesterol ratio", 
                "safety_issue": "No", 
                "time_frame": "change from baseline to 6 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01985204"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Swiss Federal Institute of Technology", 
            "investigator_full_name": "Isabelle Aeberli", 
            "investigator_title": "PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "fasting glucose", 
                "safety_issue": "No", 
                "time_frame": "baseline, 3 months and 6 months"
            }, 
            {
                "measure": "plasma leptin", 
                "safety_issue": "No", 
                "time_frame": "baseline, 3 months and 6 months"
            }, 
            {
                "measure": "LDL cholesterol", 
                "safety_issue": "No", 
                "time_frame": "baseline, 3 months and 6 months"
            }, 
            {
                "measure": "HDL cholesterol", 
                "safety_issue": "No", 
                "time_frame": "baseline, 3 months and 6 months"
            }, 
            {
                "measure": "Urinary iodine", 
                "safety_issue": "No", 
                "time_frame": "change from baseline to 6 months"
            }
        ], 
        "source": "Swiss Federal Institute of Technology", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Swiss Federal Institute of Technology", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "June 2014"
    }
}